Ed Mills, TOGETHER Principal Investigator, Mar 6 '21 on IVM dosing:
"We're doing 3 days of dosing [..] That's what's being administered"
TOGETHER IVM study, New England Journal of Medicine:
"Our study involved patients assigned between Mar 23 '21 - Aug 6 '21" (paraphrased)
